This acquisition expands Black Gold’s sustainable reverse supply chain capabilities across batteries, plastics, and solar ...
51mon MSN
TG Therapeutics raises BRIUMVI 2025 revenue guidance to $585M while advancing subcutaneous pipeline
Q3 2025 Management View CEO Michael Weiss reported, "Our flagship product, BRIUMVI for relapsing MS continues to outperform, exemplifying what happens when innovation meets execution. We've always ...
Why the current system is broken and what local governments, nonprofits, and philanthropists could do to change it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback